Literature DB >> 10447254

A summary of mutations in the UV-sensitive disorders: xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy.

J E Cleaver1, L H Thompson, A S Richardson, J C States.   

Abstract

The human diseases xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy are caused by mutations in a set of interacting gene products, which carry out the process of nucleotide excision repair. The majority of the genes have now been cloned and many mutations in the genes identified. The relationships between the distribution of mutations in the genes and the clinical presentations can be used for diagnosis and for understanding the functions and the modes of interaction among the gene products. The summary presented here represents currently known mutations that can be used as the basis for future studies of the structure, function, and biochemical properties of the proteins involved in this set of complex disorders, and may allow determination of the critical sites for mutations leading to different clinical manifestations. The summary indicates where more data are needed for some complementation groups that have few reported mutations, and for the groups for which the gene(s) are not yet cloned. These include the Xeroderma pigmentosum (XP) variant, the trichothiodystrophy group A (TTDA), and ultraviolet sensitive syndrome (UVs) groups. We also recommend that the XP-group E should be defined explicitly through molecular terms, because assignment by complementation in culture has been difficult. XP-E by this definition contains only those cell lines and patients that have mutations in the small subunit, DDB2, of a damage-specific DNA binding protein.

Entities:  

Mesh:

Year:  1999        PMID: 10447254     DOI: 10.1002/(SICI)1098-1004(1999)14:1<9::AID-HUMU2>3.0.CO;2-6

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  58 in total

1.  XPB induces C1D expression to counteract UV-induced apoptosis.

Authors:  Guang Li; Juhong Liu; Mones Abu-Asab; Shibuya Masabumi; Yoshiro Maru
Journal:  Mol Cancer Res       Date:  2010-06-08       Impact factor: 5.852

2.  Ocular manifestations of trichothiodystrophy.

Authors:  Brian P Brooks; Amy H Thompson; Janine A Clayton; Chi-Chao Chan; Deborah Tamura; Wadih M Zein; Delphine Blain; Casey Hadsall; John Rowan; Kristen E Bowles; Sikandar G Khan; Takahiro Ueda; Jennifer Boyle; Kyu-Seon Oh; John J DiGiovanna; Kenneth H Kraemer
Journal:  Ophthalmology       Date:  2011-09-28       Impact factor: 12.079

Review 3.  Involvement of mismatch repair in transcription-coupled nucleotide excision repair.

Authors:  Katsutoshi Kobayashi; Peter Karran; Shinya Oda; Katsuhiko Yanaga
Journal:  Hum Cell       Date:  2005-09       Impact factor: 4.174

Review 4.  Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: a complex genotype-phenotype relationship.

Authors:  K H Kraemer; N J Patronas; R Schiffmann; B P Brooks; D Tamura; J J DiGiovanna
Journal:  Neuroscience       Date:  2007-02-01       Impact factor: 3.590

Review 5.  Chronic oxidative damage together with genome repair deficiency in the neurons is a double whammy for neurodegeneration: Is damage response signaling a potential therapeutic target?

Authors:  Haibo Wang; Prakash Dharmalingam; Velmarini Vasquez; Joy Mitra; Istvan Boldogh; K S Rao; Thomas A Kent; Sankar Mitra; Muralidhar L Hegde
Journal:  Mech Ageing Dev       Date:  2016-09-20       Impact factor: 5.432

Review 6.  Role of AKT signaling in DNA repair and clinical response to cancer therapy.

Authors:  Qun Liu; Kristen M Turner; W K Alfred Yung; Kexin Chen; Wei Zhang
Journal:  Neuro Oncol       Date:  2014-05-07       Impact factor: 12.300

7.  Two-stage dynamic DNA quality check by xeroderma pigmentosum group C protein.

Authors:  Ulrike Camenisch; Daniel Träutlein; Flurina C Clement; Jia Fei; Alfred Leitenstorfer; Elisa Ferrando-May; Hanspeter Naegeli
Journal:  EMBO J       Date:  2009-07-16       Impact factor: 11.598

8.  Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma.

Authors:  Eliezer M Van Allen; Kent W Mouw; Philip Kim; Gopa Iyer; Nikhil Wagle; Hikmat Al-Ahmadie; Cong Zhu; Irina Ostrovnaya; Gregory V Kryukov; Kevin W O'Connor; John Sfakianos; Ilana Garcia-Grossman; Jaegil Kim; Elizabeth A Guancial; Richard Bambury; Samira Bahl; Namrata Gupta; Deborah Farlow; Angela Qu; Sabina Signoretti; Justine A Barletta; Victor Reuter; Jesse Boehm; Michael Lawrence; Gad Getz; Philip Kantoff; Bernard H Bochner; Toni K Choueiri; Dean F Bajorin; David B Solit; Stacey Gabriel; Alan D'Andrea; Levi A Garraway; Jonathan E Rosenberg
Journal:  Cancer Discov       Date:  2014-08-05       Impact factor: 39.397

9.  CKN1 (MIM 216400): mutations in Cockayne syndrome type A and a new common polymorphism.

Authors:  Henian Cao; Christina Williams; Monica Carter; Robert A Hegele
Journal:  J Hum Genet       Date:  2003-12-06       Impact factor: 3.172

10.  The DNA repair genes XPB and XPD defend cells from retroviral infection.

Authors:  Kristine Yoder; Alain Sarasin; Kenneth Kraemer; Michael McIlhatton; Frederic Bushman; Richard Fishel
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.